ESR1 and breast carcinoma: IL-8 concentrations were previously reported to be higher in breast cancer cases than in healthy women [24, 28], with higher concentrations in ER-negative than ER-positive tumors [24], defining IL-8 as a possible marker of ER-negative and/or HER2-positive breast cancers [29].